Dr. Marc MansourDr. Mansour’s expertise lies in the fields of molecular biology, cellular biology and applied immunology. Dr. Mansour has presented in numerous international conferences and has published in peer-reviewed journals in the areas of cell biology and cancer vaccines. Since he joined Immunovaccine, Dr. Mansour has advanced the company’s research by tailoring the VacciMax® platform for a variety of infectious disease and cancer vaccines. Most recently, he led the development of the DepoVax™ platform and DPX-0907. He continues to lead the Immunovaccine science team in evaluating high value vaccine opportunities and tailoring the DepoVax™ platform for specific vaccine applications that are being developed in-house or in collaboration with commercial partners.